Premilinary survival results and potential beneficiaries for locally advanced nasopharyngeal carcinoma treated with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy.
机构：[1]Sichuan Cancer Hospital, Sichuan, China四川省肿瘤医院[2]Department of Radiation Oncology, Sichuan Cancer Hospital and Institution, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China四川省人民医院四川省肿瘤医院[3]Sichuan Cancer Hospital and Institute, Chengdu, China四川省肿瘤医院[4]Sichuan Cancer Hospital and Institution, Chengdu, China四川省肿瘤医院[5]Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Chengdu, China
第一作者机构：[1]Sichuan Cancer Hospital, Sichuan, China[2]Department of Radiation Oncology, Sichuan Cancer Hospital and Institution, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China[3]Sichuan Cancer Hospital and Institute, Chengdu, China[4]Sichuan Cancer Hospital and Institution, Chengdu, China[5]Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Chengdu, China
推荐引用方式(GB/T 7714)：
Feng Mei,Lang Jinyi,Li Lu,et al.Premilinary survival results and potential beneficiaries for locally advanced nasopharyngeal carcinoma treated with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy.[J].JOURNAL OF CLINICAL ONCOLOGY.2017,35:doi:10.1200/JCO.2017.35.15_suppl.6030.
APA：
Feng, Mei,Lang, Jinyi,Li, Lu,Huang, Yecai,Xu, Peng...&Wang, Weidong.(2017).Premilinary survival results and potential beneficiaries for locally advanced nasopharyngeal carcinoma treated with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy..JOURNAL OF CLINICAL ONCOLOGY,35,
MLA：
Feng, Mei,et al."Premilinary survival results and potential beneficiaries for locally advanced nasopharyngeal carcinoma treated with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy.".JOURNAL OF CLINICAL ONCOLOGY 35.(2017)
医学